Diana Swift on Muck Rack

Diana Swift

Verified
As seen in: MedPage Today, WebMD, Flipboard, Medscape, Medscape Duestch, Medscape Noticias Médicas, Medscape PT, EIN News, Veterans Today, Clinical Neurology News, Internal Medicine News and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Diana

Contact Diana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Periconceptional/Gestational Semaglutide Tied to Adverse Obstetric Outcomes

|
By Diana Swift Verified
| Medscape Verified
Mothers with overweight or obesity exposed to semaglutide before and during pregnancy had higher risks for excessive gestational weight gain, gestational diabetes, excessive fetal growth, and cesarean delivery than nonusers, a national database study in Obstetrics and Gynecology found.
Open in Who Shared Issue with article?

El uso de semaglutida en el periodo periconcepcional y gestacional se asocia a resultados obstétricos adversos

|
By Diana Swift Verified
| Medscape Noticias Médicas Verified
Las madres con sobrepeso u obesidad expuestas a semaglutida antes y durante el embarazo presentaban un mayor riesgo de aumento de peso gestacional excesivo, diabetes gestacional, crecimiento fetal excesivo y parto por cesárea que las no usuarias, según un estudio de una base de datos nacional publicado en Obstetrics and Gynecology. Yang Yu, Ph. D.
Open in Who Shared Issue with article?

A Partially Hydrolyzed Formula May Cut Childhood Allergies

|
By Diana Swift Verified
| Medscape Verified
In nonexclusively breastfed infants at high-risk for allergy, mixed-feeding with a hydrolyzed whey-based formula for the first 6 months appeared to reduce allergy risk in children up to 5 years of age. This finding emerged from the randomized double-blind Allergy Reduction Trial (ART) reported in Pediatric Allergy and Immunology by Mikaela Sekkidou, MS, a clinical dietitian at the Asthma and Allergy Center in Limassol, Cyprus, and colleagues.
Open in Who Shared Issue with article?
See all 519 licensed articles (920 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified